News|Articles|June 1, 2004

New molecular entity: Apomorphine injection

First therapy approved for “off” episodes in advanced Parkinson’s disease


Related to this article

Stafeeva-stock@adobe.com
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.